Engain Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Private

  • Employees
  • 32

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 10

Engain General Information

Description

Developer of specialized healthcare technology designed to localize and improve therapeutic products and diagnostic technologies. The company's technology includes a color change sensing platform in the field of color change detection, as well as products for treating varicose veins and disposable medical consumables through color transfer materials, medical adhesives and vascular bonding, enabling healthcare professionals to have new specialized medical devices.

Contact Information

Website
www.engain.co.kr
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Room B175, B1 Floor, The First Tower, 10, Dongtan-daero 21-gil
  • Yeongcheon-dong
  • Hwaseong, Gyeonggi 18471
  • South Korea
+82
Primary Industry
Therapeutic Devices
Other Industries
Biotechnology
Diagnostic Equipment
Vertical(s)
Life Sciences
Corporate Office
  • Room B175, B1 Floor, The First Tower, 10, Dongtan-daero 21-gil
  • Yeongcheon-dong
  • Hwaseong, Gyeonggi 18471
  • South Korea
+82

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Engain Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC 01-Apr-2026 Completed Generating Revenue
5. Secondary Transaction - Private Completed Generating Revenue
4. Later Stage VC (Series C) 30-Nov-2020 Completed Generating Revenue
3. Later Stage VC (Series B) 31-Aug-2018 Completed Generating Revenue
2. Later Stage VC (Series A) 30-Jun-2017 Completed Generating Revenue
1. Seed Round Completed Generating Revenue
To view Engain’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Engain Patents

  • 24

    Total Documents Applications and Grants

  • Total Patents Families

  • 15

    Granted

  • 6

    Pending

  • Expiring in next 12 mo

Engain Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4323026-A1 Embolic material for relieving or treating musculoskeletal pain comprising fast dissolving gelatin particles Pending 17-May-2021
EP-4323026-A4 Embolic material for relieving or treating musculoskeletal pain comprising fast dissolving gelatin particles Pending 17-May-2021
JP-2025156501-A Embolic material for relieving or treating musculoskeletal pain comprising fast dissolving gelatin particles Pending 17-May-2021
US-20240366228-A1 Embolic material for relieving or treating musculoskeletal pain comprising fast dissolving gelatin particles Pending 17-May-2021
WO-2022244921-A1 Embolic material for relieving or treating musculoskeletal pain comprising fast dissolving gelatin particles Inactive 17-May-2021 A61L24/104
To view Engain’s complete patent history, request access »

Engain Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Engain Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds
nbloc Investment Venture Capital Minority
Ulmus Investment Venture Capital Minority
AJU IB Investment Venture Capital Minority
Genaxis (Korea) Venture Capital Minority
HB Investment Venture Capital Minority
You’re viewing 5 of 10 investors. Get the full list »

Ready to get started?

Request a free trial

Engain FAQs

  • When was Engain founded?

    Engain was founded in 2011.

  • Where is Engain headquartered?

    Engain is headquartered in Hwaseong, South Korea.

  • What is the size of Engain?

    Engain has 32 total employees.

  • What industry is Engain in?

    Engain’s primary industry is Therapeutic Devices.

  • Is Engain a private or public company?

    Engain is a Private company.

  • What is Engain’s current revenue?

    The current revenue for Engain is .

  • Who are Engain’s investors?

    nbloc Investment, Ulmus Investment, AJU IB Investment, Genaxis (Korea), and HB Investment are 5 of 10 investors who have invested in Engain.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process